Clinical Trial Update: Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating eptifibatide for extended-window ischemic stroke after thrombolysis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING